ロード中...
Rivaroxaban for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation and Active Cancer
Rivaroxaban is broadly used for the primary prevention of stroke and systemic embolism in the general population with non-valvular atrial fibrillation (AF). However, there is little published evidence on the safety and efficacy of rivaroxaban for AF in patients with active cancer. The aim of this st...
保存先:
| 出版年: | Am J Cardiol |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5523442/ https://ncbi.nlm.nih.gov/pubmed/28549819 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amjcard.2017.04.009 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|